BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15570015)

  • 21. Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review.
    Jang JY; Im E; Kim ND
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets.
    Kundu JK; Surh YJ
    Mutat Res; 2004 Nov; 555(1-2):65-80. PubMed ID: 15476852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways.
    Roy P; Kalra N; Prasad S; George J; Shukla Y
    Pharm Res; 2009 Jan; 26(1):211-7. PubMed ID: 18791811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer: chemopreventive role of curcumin and resveratrol.
    Patel VB; Misra S; Patel BB; Majumdar AP
    Nutr Cancer; 2010; 62(7):958-67. PubMed ID: 20924971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The resveratrol analogue 4,4'-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol.
    Savio M; Coppa T; Bianchi L; Vannini V; Maga G; Forti L; Cazzalini O; Lazzè MC; Perucca P; Prosperi E; Stivala LA
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2493-502. PubMed ID: 19679195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential of resveratrol in anticancer and anti-inflammatory therapy.
    Udenigwe CC; Ramprasath VR; Aluko RE; Jones PJ
    Nutr Rev; 2008 Aug; 66(8):445-54. PubMed ID: 18667005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol: a review of preclinical studies for human cancer prevention.
    Athar M; Back JH; Tang X; Kim KH; Kopelovich L; Bickers DR; Kim AL
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):274-83. PubMed ID: 17306316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From French Paradox to cancer treatment: anti-cancer activities and mechanisms of resveratrol.
    Yang X; Li X; Ren J
    Anticancer Agents Med Chem; 2014; 14(6):806-25. PubMed ID: 24851878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol from red grapes - pedestrian polyphenol or useful anticancer agent?
    Gescher AJ
    Planta Med; 2008 Oct; 74(13):1651-5. PubMed ID: 18446674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment.
    Liao W; Wei H; Wang X; Qiu Y; Gou X; Zhang X; Zhou M; Wu J; Wu T; Kou F; Zhang Y; Bian Z; Xie G; Jia W
    J Proteome Res; 2012 Jun; 11(6):3436-48. PubMed ID: 22519469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis.
    Bishayee A; Dhir N
    Chem Biol Interact; 2009 May; 179(2-3):131-44. PubMed ID: 19073162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Soybean" in a Haystack? pinpointing an anti-cancer effect.
    Gottlieb N
    J Natl Cancer Inst; 1999 Oct; 91(19):1610-2. PubMed ID: 10511585
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological and dietary agents for colorectal cancer chemoprevention: effects on polyamine metabolism (review).
    Linsalata M; Orlando A; Russo F
    Int J Oncol; 2014 Nov; 45(5):1802-12. PubMed ID: 25119812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.
    Tomé-Carneiro J; Larrosa M; González-Sarrías A; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Curr Pharm Des; 2013; 19(34):6064-93. PubMed ID: 23448440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer chemopreventive activity of resveratrol.
    Jang M; Pezzuto JM
    Drugs Exp Clin Res; 1999; 25(2-3):65-77. PubMed ID: 10370867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms.
    Yin TF; Wang M; Qing Y; Lin YM; Wu D
    World J Gastroenterol; 2016 Aug; 22(31):7058-68. PubMed ID: 27610016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol and chemoprevention.
    Goswami SK; Das DK
    Cancer Lett; 2009 Oct; 284(1):1-6. PubMed ID: 19261378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological actions and molecular effects of resveratrol, pterostilbene, and 3'-hydroxypterostilbene.
    Tsai HY; Ho CT; Chen YK
    J Food Drug Anal; 2017 Jan; 25(1):134-147. PubMed ID: 28911531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses.
    Whyte L; Huang YY; Torres K; Mehta RG
    Cancer Res; 2007 Dec; 67(24):12007-17. PubMed ID: 18089832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation.
    Ahmad A; Farhan Asad S; Singh S; Hadi SM
    Cancer Lett; 2000 Jun; 154(1):29-37. PubMed ID: 10799736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.